Sheel Biotech IPO
IPO Listing Details
- Listing Date
08 Oct 2025
- Listing Price
₹ 91.00
- Listing Change
44.44%
- Last Traded Price
₹ 78.55
Sheel Biotech IPO Details
-
Open Date
30 Sep 2025
-
Close Date
03 Oct 2025
-
Listing Date
08 Oct 2025
- IPO Price Range
₹ 59 to ₹63
- IPO Size
₹ 34.02 Cr
- Listing Exchange
NSE SME
Sheel Biotech IPO Timeline
Sheel Biotech IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 30-Sep-25 | 0.00 | 0.13 | 0.08 | 0.07 |
| 01-Oct-25 | 0.02 | 0.15 | 0.52 | 0.30 |
| 03-Oct-25 | 19.73 | 25.92 | 9.56 | 15.97 |
Last Updated: 03 October 2025 6:50 PM by 5paisa
Sheel Biotech Limited, launching a ₹34.02 crores IPO, specialises in biotechnology, floriculture, greenhouses, and organic farming. The company produces high-quality, disease-free plants for fruits, vegetables, ornamentals, and field crops via tissue culture and hydroponics. It designs and maintains greenhouses, offers landscaping, manages Farmer Producer Organisations, and provides organic certification and training. Holding ISO 9001, 14001, and 45001 certifications, its R&D lab is recognised by India’s DBT and DST, reflecting a commitment to quality, safety, and innovation.
Established in: 1991
Managing Director: Divye Chandak
Peers:
Jain Irrigation System Limited
Sheel Biotech Objectives
The company plans to allocate ₹9.12 crore towards capital expenditure requirements.
Around ₹15.88 crore will be utilised to meet working capital needs.
The remaining funds will be used for general corporate purposes.
Sheel Biotech IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹34.02 Cr |
| Offer For Sale | - |
| Fresh Issue | ₹34.02 C |
Sheel Biotech IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | 2,36,000 |
| Retail (Max) | 2 | 4,000 | 2,52,000 |
Sheel Biotech IPO Reservation
| Investors Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB | 19.73 | 10,26,000 | 2,02,44,000 | 127.537 |
| NII (HNI) | 25.92 | 7,74,000 | 2,00,62,000 | 126.391 |
| Retail Investors | 9.56 | 18,04,000 | 1,72,40,000 | 108.612 |
| Total** | 15.97 | 36,04,000 | 5,75,46,000 | 362.540 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
Strengths
1. Diverse portfolio across biotech and agriculture sectors.
2. ISO-certified operations ensure quality and safety.
3. Recognised R&D by DBT and DST.
4. Strong expertise in greenhouse and tissue culture.
Weaknesses
1. High dependency on seasonal agricultural demand.
2. Limited global presence and brand visibility.
3. Capital-intensive projects require significant investment.
4. Slow scalability due to technical expertise needs.
Opportunities
1. Rising demand for organic and sustainable farming.
2. Government support for agri-tech and FPO initiatives.
3. Growing export potential for quality planting material.
4. Expansion into precision farming and automation solutions.
Threats
1. Climate change impacts agricultural productivity.
2. Intense competition from local and global players.
3. Regulatory changes may affect organic certification.
4. Price volatility in agricultural input markets.
1. Strong presence in high-growth agri-biotech sector.
2. Diversified revenue streams across multiple verticals.
3. Recognised R&D driving innovation and product quality.
4. Positioned to benefit from sustainable farming demand.
India’s biotechnology and agri-tech sectors are expanding rapidly, driven by rising demand for sustainable farming, organic produce, and advanced cultivation technologies. With increasing government support, growing export opportunities, and adoption of greenhouse and tissue culture solutions, the industry offers significant growth prospects. Sheel Biotech’s integrated services, strong R&D capabilities, and established market presence position it well to capitalise on these trends and deliver long-term value.
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Sheel Biotech IPO opens from September 30, 2025 to October 3, 2025.
The size of Sheel Biotech IPO is ₹34.02 Cr
The price band of Sheel Biotech IPO is fixed at ₹59 to ₹63 per share.
To apply for Sheel Biotech IPO, follow the steps given below:
● Login to your 5paisa demat account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Sheel Biotech IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
You will receive a mandate notification to block funds in your UPI app.
The minimum lot size of Sheel Biotech IPO is of 4,000 shares and the investment required is ₹2,36,000.
The share allotment date of Sheel Biotech IPO is October 6, 2025
The Sheel Biotech IPO will likely be listed on October 8, 2025.
Narnolia Financial Services Ltd is the book running lead manager for Sheel Biotech IPO.
Sheel Biotech IPO plans to utilise the raised capital from the IPO for:
● The company plans to allocate ₹9.12 crore towards capital expenditure requirements.
● Around ₹15.88 crore will be utilised to meet working capital needs.
● The remaining funds will be used for general corporate purposes.
Sheel Biotech Contact Details
8 Balaji Estates
, 2nd Floor, Block-C, Guru Ravidas Marg
Kalkaji
South Delhi, New Delhi, 110019
Phone: +91 88511 - 8980
Email: compliance@sheelbiotech.com
Website: http://www.sheelbiotech.com/
Sheel Biotech IPO Register
Narnolia Financial Services Ltd
Sheel Biotech IPO Lead Manager
Skyline Financial Services Pvt.Ltd.
Phone: 02228511022
Email: compliances@skylinerta.com
Website: https://www.skylinerta.com/ipo.php